• March 20, 2022

Qualicaps®, with a proven experience in the field of inhaled drug delivery, offer a complete spectrum of services surrounding the hard capsules dosage form, able to present our customers with the option of either start-to-finish development or focused support at any critical stage of the drug product’s life cycle.

  • August 20, 2021

Precise, predictive, PK data – Inhalation Research Services preclinical data are powerful, predictive and precise, showing where and how Candidate Drugs (CDs) behave in all regions of the lung early on. Reduce risk; prevent clinical failure; optimize pipeline planning; eliminate weak CDs early on; discover new CD modalities early on.

  • August 25, 2020

Lonza Pharma & Biotech provides integrated DPI (dry powder inhaler) development services to advance molecules, drawing on 25 years of experience in particle engineering, formulation design, and encapsulation techniques. Our premier particle engineering technologies services, utilizing both jet milling and spray drying, are tailored to your molecule, target product profile and delivery device. Dedicated DPI […]

  • March 3, 2020

We are a full-service, Clinical Research Organization (CRO) that specializes in respiratory studies.

  • March 5, 2018

Integrated services from preformulation, analytical testing and clinical supply to commercial manufacturing and packaging for all inhaled dosage forms including pMDI, DPI, nasal sprays, solution/suspension for inhalation.